Pfizer/BioNTech’s Covid-19 vaccine mega deal ousts AstraZeneca from EU; Moderna, J&J best positioned for more preorders but minimal
Moderna and Johnson & Johnson still have opportunities to secure additional advance purchase agreements from the European Commission (EC) for their Covid-19 vaccines, but there are significant obstacles to doing so, pricing and reimbursement experts said.
Comments